Canonical: https://ownershiptrace.com/13f/companies/221

# Who owns Dianthus Therapeutics, Inc. /DE/ (DNTH)? Elite investor 13F holders

3 tracked elite investors reported holding Dianthus Therapeutics, Inc. /DE/ as of 2026-06-30, including D.E. Shaw, Tudor Investment, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | DIANTHUS THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4184621.00 USD | 42928.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | DIANTHUS THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3636784.00 USD | 37308.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | DIANTHUS THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 909781.00 USD | 9333.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)